ACHIEVEMENT OF LOW DISEASE ACTIVITY IN PATIENTS INITIATING INFLIXIMAB WITH AND WITHOUT DOSE ESCALATION

被引：0

作者：

Cohen, S. ^{[1
]}

Reed, G. ^{[2
]}

Magner, R. ^{[3
]}

Kafka, S. ^{[4
]}

Ellis, L. ^{[4
]}

DeHoratius, R. J. ^{[5
]}

Greenberg, J. D. ^{[6
]}

机构：

[1] Metroplex Clin Res Ctr, Dallas, TX USA

[2] LLC Mass Med Sch, Corrona, Southborough, MA USA

[3] U Mass Med Sch, Worcester, MA USA

[4] Janssen Sci Affairs LLC, Horsham, PA USA

[5] Horsham Phila, LLC Kimmel Sch Med, Janssen Sci Affairs, Horsham, PA USA

[6] NYU, LLC, Sch Med, Corrona, Southborough, NY USA

来源：

ANNALS OF THE RHEUMATIC DISEASES | 2016年 / 75卷

关键词：

D O I：

10.1136/annrheumdis-2016-eular.2771

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

THU0156

引用

页码：238 / 239

页数：2

共 50 条

[21] Double-blinded infliximab dose escalation in patients with rheumatoid arthritis [J].

Rahman, Mahboob U. ;

Strusberg, Ingrid ;

Geusens, Piet ;

Berman, Alberto ;

Yocum, David ;

Baker, Daniel ;

Wagner, Carrie ;

Han, John ;

Westhovens, Rene .

ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 (09) :1233-1238

[22] Prediction of dose escalation for rheumatoid arthritis patients under infliximab treatment [J].

Van Looy, Stijn ;

Cruyssen, Bert Vander ;

Meeus, Jeroen ;

Wyns, Bart ;

Westhovens, Rene ;

Durez, Patrick ;

Van den Bosch, Filip ;

Vastesaeger, Nathan ;

Geldhof, Anja ;

Boullart, Luc ;

De Keyser, Filip .

ENGINEERING APPLICATIONS OF ARTIFICIAL INTELLIGENCE, 2006, 19 (07) :819-828

[23] WEEK 10 INFLIXIMAB CONCENTRATION IDENTIFIES PATIENTS THAT REQUIRE EARLY DOSE ESCALATION IN INFLAMMATORY BOWEL DISEASE [J].

Salem, Mark ;

Ha, Christina ;

Syal, Gaurav .

GASTROENTEROLOGY, 2019, 156 (03) :S38-S39

[24] WEEK 10 INFLIXIMAB CONCENTRATION IDENTIFIES PATIENTS THAT REQUIRE EARLY DOSE ESCALATION IN INFLAMMATORY BOWEL DISEASE [J].

Salem, Mark ;

Ha, Christina ;

Syal, Gaurav .

INFLAMMATORY BOWEL DISEASES, 2019, 25 :S27-S27

[25] Infliximab dose escalation in patients with rheumatoid arthritis: Results from the start trial [J].

Westhovens, R ;

Wolfe, F ;

Rahman, MU ;

Han, J ;

Yocum, D .

ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 :423-423

[26] Adalimumab Dose-Escalation Therapy Is Effective in Refractory Crohn's Disease Patients with Loss of Response to Adalimumab, Especially in Cases without Previous Infliximab Treatment [J].

Suzuki, Taketo ;

Mizoshita, Tsutomu ;

Sugiyama, Tomoya ;

Hirata, Yoshikazu ;

Kimura, Yoshihide ;

Suzuki, Yuka ;

Yamada, Tomonori ;

Tsukamoto, Hironobu ;

Mizushima, Takashi ;

Sugimura, Naomi ;

Katano, Takahito ;

Tanida, Satoshi ;

Kataoka, Hiromi ;

Sasaki, Makoto .

CASE REPORTS IN GASTROENTEROLOGY, 2019, 13 (01) :37-49

[27] RETROSPECTIVE STUDY OF DOSE ESCALATION WITH ADALIMUMAB, INFLIXIMAB, AND VEDOLIZUMAB IN THE TREATMENT OF INFLAMMATORY BOWEL DISEASE [J].

Zhang, K. H. ;

Singh, H. ;

Twardowski, R. ;

Lu, C. ;

Wan, Y. ;

Null, K. .

VALUE IN HEALTH, 2020, 23 :S143-S143

[28] Long-term Durability of Infliximab Treatment in Crohn's Disease and Efficacy of Dose "Escalation" in Patients Losing Response [J].

Chaparro, Maria ;

Panes, Julian ;

Garcia, Valle ;

Manosa, Miriam ;

Esteve, Maria ;

Merino, Olga ;

Andreu, Montserrat ;

Gutierrez, Ana ;

Gomollon, Fernando ;

Luis Cabriada, Jose ;

Angel Montoro, Miguel ;

Luis Mendoza, Juan ;

Nos, Pilar ;

Gisbert, Javier P. .

JOURNAL OF CLINICAL GASTROENTEROLOGY, 2011, 45 (02) :113-118

[29] Retrospective Database Analysis: Dose Escalation and Adherence in Patients Initiating Biologics for Ulcerative Colitis [J].

Long, Millie D. D. ;

Cohen, Russell D. D. ;

Smith, Timothy W. W. ;

DiBonaventura, Marco ;

Gruben, David ;

Bargo, Danielle ;

Salese, Leonardo ;

Quirk, Daniel .

DIGESTIVE DISEASES, 2021, :553-564

[30] Infliximab dose escalation in patients with rheumatoid arthritis: Results from the START trial. [J].

Westhovens, R ;

Wolfe, F ;

Rahman, MU ;

Han, J ;

Yocum, D .

ARTHRITIS AND RHEUMATISM, 2004, 50 (09) :S185-S186

← 1 2 3 4 5 →